Adage Capital Management L.P. 13D and 13G filings for Aligos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:32 am Purchase | 2024-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Adage Capital Management L.P. | 325,000 9.380% | 106,187 (+48.53%) | Filing |
| 2024-11-12 09:31 am Purchase | 2024-09-30 | 13G | Aligos Therapeutics, Inc. ALGS | Adage Capital Management L.P. | 218,813 7.120% | 218,813 (New Position) | Filing |